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what administration intervals are used in the development and validation of 
PROs, as a first step towards ascertaining the most appropriate interval between 
administrations for test-retest and equivalence studies for different measures. 
METHODS: A literature review was conducted using the following search terms: 
test retest reliability, equivalence testing, washout period, and interval on 
Psychinfo since January 2003. 554 abstracts were identified. Thirty-two 
additional abstracts from an equivalence study review paper were included 
resulting in a total of 586 abstracts. All abstracts were reviewed and where 
available the administration interval was extracted and collated. RESULTS: One 
percent of the test retest studies had an interval of one hour or less, 18% had an 
interval of 1 day to 1 week, 25% had an interval of 1weeks to 2 weeks, 21% had an 
interval of 2 weeks to 1 month, 9% had an interval of 1 to 2 month, 13 % had an 
interval of 2 months or over, 13% reported a varied interval. In contrast, 50% of 
the equivalence studies had an administration interval of 1 hour or less, 9% had 
an interval of 1 hour to 1 day, 28% had an interval of 1 day to 1 week, 3% an 
interval of 1 to 2 weeks 10% reported a varied interval within the same study. 
CONCLUSIONS: There is a wide variety of administration intervals used in test-
retest and equivalence studies seen within the literature. Considerations around 
the appropriate administration interval to use should be based on, amongst 
other things, an assessment of the stability of the condition involved and the 
complexity of the PRO.  
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THE NOCTURIA IMPACT DIARY® – A NEW PATIENT REPORTED OUTCOME (PRO) 
INSTRUMENT DEVELOPED IN CLOSE DIALOG WITH THE FDA  
Holm-Larsen T1, Andersson F2, van der Meulen E2, Rosen RC3, Norgaard JP4 
1Pharma Evidence, Farum, Denmark, 2Ferring Pharmaceuticals A/S, Copenhagen, Denmark, 
3New England Research Institute, Watertown, MA, USA, 4Ferring Pharmaceutical A/S, 
Copenhagen, Denmark  
OBJECTIVES: Current questionnaires assessing the impact of nocturia (waking up 
at night one or more times to void), e.g. N-QoL, ICIQ-N or IPSS, do not fulfill the new 
FDA PRO guidelines. We report on the development of a new nocturia impact 
measure. METHODS: The following recommended steps were undertaken: 1) 
Literature review identifying an exhaustive pool of concepts, hereafter 
development of draft diary; 2) Cognitive debriefing test (n=23) confirming 
relevance and importance of items and understandability of phrasing. 
Preliminary Rasch analysis. Modified diary developed and 3) Reliability, validity, 
sensitivity and dimensionality tested in randomized, placebo-controlled trial 
(n=56). RESULTS: Step 1 generated 4 domains including 14 items with 5 response 
options (‘a great deal’ to ‘not at all’). Step 2: Content validity supported 11 items 
and suggested 1 new. Revision into a 12-item diary with 2 domain scores. Step 3: 
Dimensionality: Factor and Rasch analyses clearly indicated uni-dimensionality. 
Construct Validity: Known group validity (<3/≥3 voids): Total score D-13.6 points 
at baseline, p=0.03. Fit to Rasch model at baseline 2 of 3 p= >0.05. Reliability: 
Stability over time=0.91. Internal consistency: Cronbachs alpha=0.9. Sensitivity: 
Cohen’s D=0.73. High variance in response options, slight floor effect. Person 
correlation with number of voids=0.31, p=0.02. Final NI diary: Nocturia Impact 
total score calculated from 11 core items. Global impact question (Q12) analyzed 
separately. CONCLUSIONS: All validity and reliability tests of the Nocturia 
Impact Diary® were highly supportive. The sensitivity was acceptable, especially 
the calculation of Cohen’s D based on pooled analysis. The Nocturia Impact 
Diary® is the first nocturia impact assessment tool developed in close dialog with 
FDA and in accordance with the new PRO guidelines. Consequently, it represents 
a valid new tool within nocturia and should be used in conjunction with voiding 
diaries in cross sectional assessments of patient burden or in assessments of 
changes due to treatment of nocturia.  
 
PRM155  
USING QUESTIONNAIRE DESIGN TO EXPLORE REPORTING DIFFERENCES FOR 
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OBJECTIVES: To utilize a specific approach in questionnaire design (general to 
specific items) to identify evidences of existing (but initially denied) spasticity-
related pain (SRP) in children with Cerebral Palsy (CP). METHODS: Children and 
adolescents with CP and SRP and their parent/caregivers participated in 
qualitative interviews to evaluate the Questionnaire on Pain Caused by Spasticity 
(QPS), a newly developed Patient Reported and Observer Reported Outcome 
measure that assesses SRP. Interviews were audio recorded and transcribed. 
Child/adolescent questionnaires were compared with the one from their 
corresponding parent/caregiver’s to identify differences in answers provided for 
presence of SRP. Questions first asked about SRP in general, and then in specific 
activity situations (at rest, during usual daily activities, during active 
mobilization, and during physically difficult activities). RESULTS: Eight children 
and adolescents (7-16 years) who participated with their parent/caregivers were 
used for this evaluation. Clinicians confirmed at enrollment that all subjects had 
SRP weekly to daily. Four of the 8 participants reported having no pain on the 
initial general SRP item, yet proceeded to describe their pain in subsequent items 
that asked about severity of pain in specific activity situations. Parent/caregiver 
responses indicated observation of signs of their child’s pain on both the general 
item and the various activity situations. CONCLUSIONS: Because earlier 
qualitative interview data documented instances where children and 
adolescents reported intentionally hiding their pain from their parent/caregivers, 
there is a concern that self-reported pain data may not be trustworthy in this 
population. However, these findings suggest that combining a self-reported and 
an observer-reported assessment produces complimentary results that facilitate 
more accurate measurement of SRP. Results also suggest that in the assessment 
of chronic conditions, structuring child/adolescent questionnaires to make 
multiple (general to descriptive) inquiries of the same concept might facilitate 
discovery of symptoms being initially denied.  
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DETERMINING SUBJECT PREFERENCE FOR ITEMS USING IDIOMATIC OR LITERAL 
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OBJECTIVES: To review both idiomatic items and items with literal phrasing 
within Patient Reported Outcomes instruments in order to assess subject 
comprehension and preference. Idiomatic items commonly appear in 
psychological questionnaires and clinical outcomes assessments, and frequently 
require translation for use in multinational clinical trials. Though it is theorized 
that idiomatic items will be more comprehensible to lay audiences, previous 
research has shown that they require more rounds of revision during linguistic 
validation in order to achieve conceptual equivalence. METHODS: A patient 
questionnaire containing six idiomatic items underwent linguistic validation in 
six languages. For each item, a literal equivalent was developed and translated. 
During cognitive debriefing, a sample of 147 subjects was presented with both 
idiomatic and literal versions of the six items. Subjects were asked to comment 
on comprehensibility and preference. A control group of 7 subjects was asked for 
feedback on these items in U.S. English. RESULTS: Cognitive debriefing data 
showed preference for the literal item 59% of the time, and for the idiomatic item 
37% of the time. Subjects made no decision 4% of the time. No correlation was 
found between years of education and preference. Only 2 instances of 
comprehension issues occurred, both with the idiomatic items. Literal items 
yielded no comprehension issues. In some languages, an idiomatic equivalent 
was unavailable; these items were omitted from the analysis. Subjects in the 
English-U.S. control group preferred the literal item 74% of the time. 
CONCLUSIONS: In previous research, idiomatic items were shown to require one 
to two more rounds of revision than literal items during translation. Given that 
literal items were understood by all sample members with less than 12 years of 
education, and were preferred by a majority, avoidance of idiomatic items in 
patient questionnaires is recommended.  
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VALIDATION AND PSYCHOMETRIC EVALUATION OF A PATIENT-REPORTED 
ASSESSMENT OF DISEASE BURDEN: EVIDENCE FROM A SAMPLE OF ADULTS 
WITH DIABETES, DEPRESSION, AND RHEUMATOID ARTHRITIS  
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OBJECTIVES: The Disease Burden Scale (DBS), a 4-item instrument derived from 
the Diabetes Burden Scale (Kaplan 2010), measures the impact of specific health 
conditions on a patient’s overall health, social activities, lifestyle and finances. 
We sought to build on prior validation of the parent instrument by evaluating 
the validity and reproducibility of the DBS and testing equivalence between 
paper and electronic administration modes. METHODS: Adult patients with 
depression, type 2 diabetes, or rheumatoid arthritis were recruited through web-
based advertisements in 8 U.S. cities and completed the DBS on both paper and 
computerized format in a randomized crossover design. A one-week retest was 
also completed. Reproducibility and mode equivalence were assessed using the 
intraclass correlation coefficient (ICC). Cronbach’s alpha was calculated to assess 
internal consistency. To assess convergent validity, the correlation of the DBS to 
the WHO Quality of Life Scale (WHOQOL-BREF) was calculated. ANOVA was used 
to compare mean DBS scores among known groups defined by the MOS-36 MCS 
and PCS subscales. RESULTS: Of the 230 participants that completed baseline 
assessment, 228 (99.1%) completed the one-week retest. The mean age of 
participants was 44.3 years, 51.3% were female, and 58.3% were Caucasian. A 
small amount (n=9; 3.9%) reported their health as Poor. The mean paper DBS 
score was 44.8 (±26.6), and the ICC between paper and computerized 
administration was 0.876. The ICC for the one-week retest of the paper format 
was 0.944, and the DBS was found to be internally consistent (Cronbach’s 
alpha=0.899). Significant correlations were found with the WHOQOL-BREF 
(r=0.460 to 0.646; p<0.01) and the instrument discriminated between 
hypothesized MOS-36 score groups (MCS, p<0.01; PCS, p<0.01). CONCLUSIONS: 
The DBS was observed to be reproducible and internally consistent, 
demonstrated appropriate convergent validity, and significantly discriminated 
between levels of overall health status. Equivalence between paper and web-
based administration was demonstrated.  
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OBJECTIVES: Axial spondyloarthritis (axSpA) includes both ankylosing 
spondylitis (AS) and non-radiographic axSpA (nr-axSpA, axSpA with no 
definitive sacroiliitis on X-ray). Several patient-reported outcome (PRO) 
instruments have been validated in AS. This study evaluated the content 
validity, and assessed the psychometric measurement properties, of such PROs 
in the broad axSpA population. METHODS: PROs assessed: Total and Nocturnal 
Spinal Pain Numerical Rating Scales, PtGA, BASDAI (including fatigue and 
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morning stiffness), BASFI, ASQoL and the SF-36. Literature review, and clinician 
and patient interviews, provided information on instrument content validity. 
Statistical analysis of measurement properties evaluated the reliability (test-
retest and internal consistency), responsiveness and construct validity. 
Measurement properties were assessed using data from the RAPID-axSpA trial 
investigating certolizumab pegol (CZP) efficacy in axSpA. RESULTS: Reviewed AS 
literature revealed relevant concepts: physical function, pain, disease activity, 
morning stiffness, fatigue, disturbed sleep, depression, mobility problems, 
problems performing recreational activities/household tasks/self-care/work, and 
problems socializing. The same concepts were evident for the overall axSpA 
population in expert interviews. Concepts identified in patient interviews were 
consonant with both literature and expert opinion. All PRO instruments were 
satisfactorily reliable in the RAPID-axSpA population, with all test-retest intra-
class correlation coefficients and internal consistency Cronbach’s alphas >0.8. 
Validity was supported by agreement between PRO and clinician-rated 
measures. All the PRO measures showed good sensitivity to change, with large 
response sizes (effect size >0.8) on almost all measures from week 12 in RAPID-
axSpA. No significant variations in psychometric properties were noted between 
axSpA sub-populations. CONCLUSIONS: This study indicates that both the 
content validity and the measurement properties of PRO instruments used in AS 
are preserved in the broad axSpA population. Questions remain about relying on 
classical test theory for validation and the value of using generic outcome 
measures when well-developed disease-specific measures are available.  
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OBJECTIVES: Lead-time time trade-off (TTO) is a promising alternative to 
conventional TTO. The purpose of this study was to compare the values of EQ-
5D-5L health states as measured by two TTO variants using different ratios of 
lead time to unhealthy time. METHODS: Data were collected as part of a wider 
multi-country pilot study. We elicited the values of 10 selected EQ-5D-5L health 
states from a convenience general population sample (N=406) using two lead-
time TTO variants: 10 years of lead time in full health preceding 5 years of 
unhealthy time (standard method), and 5 years of lead time preceding 5 years of 
unhealthy time (experimental method). Participants self-completed the tasks 
using personal computers, with an interviewer supervising groups of 
participants. Participants were randomized to receive one of the two TTO 
variants to value a block of 5 EQ-5D-5L states. The TTO values were compared 
between the two study arms using random-effects linear models, with 
adjustment of age, gender, education, and health states. RESULTS: Health-state 
values generated from TTO valuation exercises using the longer lead time were 
slightly lower than those generated from exercises using the shorter lead time. 
The proportion of non-negative values in the standard and experimental arms 
was 81.2% and 86.7%, respectively (p=0.046); the grand mean TTO value was 0.35 
and 0.43 for the standard and experimental arms, respectively (p=0.049). 
Exhaustion of tradable time occurred only in the experimental arm (0.46%) 
where the lead time was shorter. CONCLUSIONS: This study confirms earlier 
findings that the ratio of lead time to time in poor health exerts an effect on TTO 
values of health states. The more lead time is offered, the more time is traded. 
Different lead-time TTO variants should be carefully studied in order to achieve 
the best measurement of health-state values using this new method.  
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DEAD TODAY OR DIE TOMORROW? A LITERATURE REVIEW OF THE EMPIRICAL 
EVIDENCE FOR INTER-TEMPORAL PREFERENCES OF HEALTH  
Byrnes J 
Griffith University, Meadowbrook, Australia  
OBJECTIVES: Time preferences and discounting has become indoctrinated in the 
evaluation of health care technologies that generate future benefits and costs. 
Moreover, it remains a fundamental economic concept that is relied upon for the 
understanding of individuals’ decision making with respect to health. The aim of 
this paper is to provide a systematic review of the empirical studies that have 
attempted to measure either individual or societal inter-temporal preferences 
regarding health. METHODS: A systematic search of peer-reviewed articles 
published in English during 1980 to 2012. The Preferred Reporting System for 
Systematic Reviews and Meta-Analysis (PRISMA) strategy was followed to ensure 
systematic selection of the papers. Articles were excluded if they did not report a 
discount rate or factor(s); and if health (and or life years) was not the domain for 
which discount estimates were provided. Two reviewers assessed the results of 
the search against a predefined exclusion and inclusion strategy to ensure 
appropriate inclusion of papers. RESULTS: A total 64 studies were identified 
within 54 published articles. A variety of methodological approaches have been 
implemented to measure preferences as well as testing over a variety of 
functional forms including hyperbolic and quasi-hyperbolic models. Estimates 
for a constant discount rate vary significantly from below zero to over 1000%. 
However, a weight of evidence in support of hyperbolic or at least non-constant 
discounting is emerging. Evidence is equivocal at best with regards to the 
relationship between time preferences measured and health behaviors. 
CONCLUSIONS: It has become common practice, and is often advised, that 
economic models of future costs and consequences should conduct sensitivity 
analyses regarding the discount rate chosen. From the empirical evidence it 
appears as important that such models also consider the sensitivity of models to 
other debatable concepts regarding discounting including the use of hyperbolic 
functions.  
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IDENTIFYING PATIENT SUBPOPULATIONS IN EARLY DEVELOPMENT TO 
SUBSTANTIATE VALUE  
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OBJECTIVES: Optimizing the clinical trial design and establishing the appropriate 
populations early in development are essential to substantiating a compelling 
value proposition. This project sought to provide an example of how a 
subpopulation investigation can inform early development strategy. METHODS: 
US 2012 National Health and Wellness Survey data were used. Respondents with 
pain in the past month were included. The distribution of work productivity 
(using the WPAI questionnaire) was examined and subpopulations of pain 
patients with particularly high or low impairment were described and compared 
to uncover groups with the highest likelihood of showing incremental benefit 
substantial enough to demonstrate value and compel funding. RESULTS: A total 
of 24,215 respondents (34.0%) reported pain in the past month (mean age=49.96; 
51.92% were female). Mean level of pain severity in the last week was 4.71 
(SD=2.72) and mean overall work productivity loss was 22.04% (SD=27.84%). 
Although these variables were significantly related (r=0.45, p<0.05), a substantial 
percentage of people with pain reported no work impairment (44.23%) creating a 
floor effect whereby regardless of the improvement in pain, no effect would be 
observed with respect to the ability to work. Conversely, 3.6% of people with pain 
reported 90% or more of their work week being impaired. Few demographic 
differences (age, sex) were observed between these two extremes, though those 
with 90%+ impairment were more likely to be obese (43.40%) versus those 
without any impairment (32.80%). CONCLUSIONS: Pain severity and work 
productivity loss were significantly related but many of those with pain reported 
so little impairment that no intervention could provide a compelling proposition. 
However, key subgroups (e.g. those obese) reported significant impairments with 
a much greater likelihood of demonstrating treatment benefit. Subgroup analysis 
early in development can identify the most relevant patient populations and 
help inform clinical trial design, optimize incremental value, and drive cost 
effectiveness.  
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CROSS-CULTURAL ADAPTATION OF A RESEARCH VERSION OF THE REY 
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OBJECTIVES: The Rey Auditory Verbal Learning Test (RAVLT) is a cognitive test 
assessing verbal learning and memory. Fifteen words (List A) are presented 
across five learning trials and queried during two delayed-recall trials. A second 
15-word list (List B) designed to interfere with recollection of the primary list is 
used. A recognition trial is administered during which subjects are asked to 
detect List A words from amidst distractor words from List B plus 20 others that 
have a semantic and/or a phonetic link with words from the lists. The objective 
of this abstract is to present the translation process of the RAVLT into Japanese. 
METHODS: For the 30 words from the two lists a direct translation was 
recommended based on collaborative efforts involving a speech therapist and a 
neuropsychologist. The goal was to maintain similar frequency of use and 
syllables (±1 syllable or ±2 syllables and ±2 characters) to the source English 
terms. For the 20 additional words used in the recognition trial, the translations 
had to respect the semantic and/or phonetic links to the words from the two 
lists. RESULTS: Discussions ensued around six of the 30 words from the lists due 
to difficulties in finding direct translations with the appropriate number of 
syllables. For the recognition words, the most problematic issue was finding 
equivalents maintaining the phonetic link to the Japanese translation. Ten 
recognition words had to be changed to uphold this linguistic property. For 
instance, the recognition word “Tree” required a phonetic link to the recall word 
“Turkey” so it was translated as “Box” (Ha Ko) to preserve the phonetic link with 
the word chosen to replace “Turkey” (i.e., “Pigeon” (Ha To)). CONCLUSIONS: This 
methodology enabled the production of a Japanese version of the RAVLT that 
preserved the intent and integrity of the source US English test.  
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OBJECTIVES: According to PhRMA, 75% of Americans are non-adherent on one or 
more of their medications. Low adherence leads to worsening of the disease and 
unnecessary health care spending. Various tools have been used by health care 
professionals to improve medication adherence. The objective of this study is to 
conduct a systematic review to identify tools used to improve medication 
adherence and their impact on medication adherence. METHODS: PRISMA 
guidelines were followed for conducting a systematic review. A comprehensive 
electronic search of research databases (PubMed, MEDLINE, EBSCO, and 
PsycINFO), was performed. Combinations of search terms were generated by 
reviewing existing literature and consulting an expert librarian. Search terms 
included the names of each tool, adherence, compliance, persistence, and 
medication adherence. Studies were included if they were conducted after 
January 2000; involved the use of an adherence tool recommended by a certified 
health care professional; and measured the rate of medication adherence as an 
outcome. Studies on measuring adherence to vaccines and lifestyle 
modifications were excluded. RESULTS: Preliminary search yielded 637 articles. 
Articles were excluded following a title review (552) and an abstract review (43). 
Forty-two studies met the criteria for full review. Six different adherence tools 
